Association of Histologic Variants in FSGS Clinical Trial with Presenting Features and Outcomes | Zendy

Vivette D. D’Agati | Zendy; Joan M. Alster | Zendy; J. Charles Jennette | Zendy; David B. Thomas | Zendy; James Pullman | Zendy; Daniel A. Savino | Zendy; Arthur H. Cohen | Zendy; Debbie S. Gipson | Zendy; Jennifer Gassman | Zendy; Milena Radeva | Zendy; Marva MoxeyMims | Zendy; Aaron L. Friedman | Zendy; Frederick J. Kaskel | Zendy; Howard Trachtman | Zendy; Charles E. Alpers | Zendy; Agnes B. Fogo | Zendy; Tom Greene | Zendy; Cynthia C. Nast | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Association of Histologic Variants in FSGS Clinical Trial with Presenting Features and Outcomes

Author(s) -

Vivette D. D’Agati,

Joan M. Alster,

J. Charles Jennette,

David B. Thomas,

James Pullman,

Daniel A. Savino,

Arthur H. Cohen,

Debbie S. Gipson,

Jennifer Gassman,

Milena Radeva,

Marva MoxeyMims,

Aaron L. Friedman,

Frederick J. Kaskel,

Howard Trachtman,

Charles E. Alpers,

Agnes B. Fogo,

Tom Greene,

Cynthia C. Nast

Publication year - 2012

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.06100612

Subject(s) - medicine , proteinuria , prospective cohort study , creatinine , hypoalbuminemia , renal function , retrospective cohort study , renal biopsy , odds ratio , biopsy , clinical trial , pathology , kidney

FSGS histologic variants have correlated with outcomes in retrospective studies. The FSGS Clinical Trial provided a unique opportunity to study the clinical impact of histologic variants in a well defined prospective cohort with steroid-resistant primary FSGS.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research